Abstract 2: Epigenetic Modulation of TGF-beta Signaling Underlies the Scarring Fibroblast Phenotype

by Heather E. desJardins-Park, AB, Alessandra L. Moore, MD, Ulrike Litzenburger, PhD, Clement D. Marshall, MD, Leandra A. Barnes, AB, Shamik Mascharak, BS, Bryan Duoto, MS, Ryan C. Ransom, BS, Deshka S. Foster, MD, Michael S. Hu, MD, H. Peter Lorenz, MD, Howard Y. Chang, MD, Michael T. Longaker, MD
Published 2019-04-01

Abstract 186: CD36 Antagonism Minimizes Skin Scarring By Inhibiting JUN-dependent Fibrotic Pathways Within Fibrogenic Fibroblast Subpopulations

by Mimi R. Borrelli, MBBS, MSc, Julia Garcia, PhD, Michelle Griffin, MD, PhD, Nestor M. Deleon Diaz, Alexandra L. Moore, MD, Shamik Mascharak, MS, Bryan Duoto, MS, Heather desJardins-Park, Sandeep Adem, MS, Tristan Lerbs, PhD, Marc Gastou, PhD, Lui Cui, PhD, Michael Januszyk, MD, PhD, Hermann P. Lorenz, MD, Derrick C. Wan, MD, Geoffrey C. Gurtner, MD, Howard Chang, MD, PhD, Gerlinde Wernig, MD, Michael T. Longaker, MD, MA
Published 2020-04-01